TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/12/2025
Voltar para busca
Dado oficial do USPTO
INTO ACCELERATING INHALATION DEVELOPMENT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
33
Atualização mais recente
04/12/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 42
Data de depósito
21/11/2022
Data de registro
18/06/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
18/06/2024
Última transação
04/12/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
IT
Examinador
BERNS,LEE ANNE
Unidade examinadora
M90
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of the stylized letter "i" with the word "INTO" in large letters situated to the right of "i" and "accelerating inhalation development" in lower case letters situated below "INTO".
Titulares e representantes
Titulares
STERLING S.P.A.
DFE Pharma GmbH & Co. KG
Harro Höfliger Verpackungsmaschinen GmbH
Representantes
Michael N. Mercanti Lucas & Mercanti, LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicalschemical additives and chemical compositionsactive chemical ingredients and excipients for use in the manufacture of pharmaceuticals for treating respiratory diseases; chemical substances for analyses in laboratoriesother than for medical or veterinary purposesuse in the manufacture of pharmaceuticals
Classe 5
Pharmaceuticalspharmaceutical preparationspharmaceuticals for medical or veterinary purposespharmaceutical compositionsvaccines and medicine being pharmaceutical preparationsall for use in the treatment of respiratory diseases
Classe 42
Pharmaceutical and chemical research services; pharmaceutical and chemical product development services for others; pharmaceutical and chemical design services being pharmaceutical and chemical product development services for others; testing of pharmaceuticals and chemicals; medical and scientific researchconducting clinical trials of pharmaceuticals for others and testing of chemicals; pharmaceutical and chemical analysis; laboratory research services relating to orally inhaled and nasal drugs products; pharmaceutical and chemical product evaluation; preparation of reports in the nature of technical writing relating to the aforesaid pharmaceutical and chemical research; inspection being testing and inspection of pharmaceuticals and chemicals; scientific and technological servicesscientific researchformulation developmentanalysis and testing in the field of orally inhaled and nasal drugs products; biological research services; quality control for others and authentication services for pharmaceuticals; informationadvice and consultancy services in relation to the aforesaid services
Publicações
Histórico de despachos e eventos da marca no USPTO.
33 publicações encontradas
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
02/12/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/12/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/12/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
22/02/2025
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
27/11/2024
XXCR
GENERIC MADRID TRANSACTION CREATED
27/11/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
18/09/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
18/06/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
18/06/2024
GPNX
NOTIFICATION PROCESSED BY IB
16/04/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/04/2024
PUBO
PUBLISHED FOR OPPOSITION
02/04/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
27/03/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
27/03/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
13/03/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
23/02/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
23/02/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
23/02/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
23/02/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
23/02/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/02/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/02/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/02/2024
RFNT
REFUSAL PROCESSED BY IB
17/10/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
27/09/2023
RFRR
REFUSAL PROCESSED BY MPU
27/09/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/09/2023
CNRT
NON-FINAL ACTION WRITTEN
10/09/2023
DOCK
ASSIGNED TO EXAMINER
03/09/2023
MAFR
APPLICATION FILING RECEIPT MAILED
22/02/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
18/02/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
16/02/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace INTO ACCELERATING INHALATION DEVELOPMENT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.